DRTS ALPHA TAU MEDICAL LTD revenue, earnings and financials

For the fiscal year ended December 2025 revenue was n/a.

DRTS annual revenue and earnings

Fiscal year ended Dec 2025: revenue n/a, gross profit n/a, operating income −$42.3M, net income −$42.6M (margin n/a), EPS −$0.53
Fiscal year ended Dec 2024: revenue n/a, gross profit n/a, operating income −$36.0M, net income −$31.8M (margin n/a), EPS −$0.45
Fiscal year ended Dec 2023: revenue n/a, gross profit n/a, operating income −$35.7M, net income −$29.2M (margin n/a), EPS −$0.42
Fiscal year ended Dec 2022: revenue n/a, gross profit n/a, operating income −$32.1M, net income −$33.8M (margin n/a), EPS −$0.53
Fiscal year ended Dec 2021: revenue n/a, gross profit n/a, operating income −$13.8M, net income −$27.3M (margin n/a), EPS −$0.67

Dec 31, 2025: cash $12.2M, total assets $106M, total liabilities $28.6M, shareholders' equity $77.1M
Jun 30, 2025: cash $11.7M, total assets $111M, total liabilities $24.3M, shareholders' equity $86.6M
Dec 31, 2024: cash $13.7M, total assets $86.2M, total liabilities $23.5M, shareholders' equity $62.7M
Jun 30, 2024: cash $2.76M, total assets $96.0M, total liabilities $22.0M, shareholders' equity $74.0M
Dec 31, 2023: cash $12.7M, total assets $107M, total liabilities $22.9M, shareholders' equity $84.5M
Jun 30, 2023: cash $855K, total assets $111M, total liabilities $18.6M, shareholders' equity $92.6M
Dec 31, 2022: cash $5.84M, total assets $120M, total liabilities $14.5M, shareholders' equity $106M
Dec 31, 2021: cash $23.2M, total assets $42.2M, total liabilities $23.0M, shareholders' equity −$34.8M

No. ALPHA TAU MEDICAL LTD lost $42.6M in its latest fiscal year.